Zobrazeno 1 - 10
of 41
pro vyhledávání: '"S F, Hain"'
Autor:
William Ramsden, Margaret Brooks, Sara Stoneham, S F Hain, Sally F. Barrington, Lorenzo Biassoni, Thomas Kane, Paul Schleyer, Joanna Begent, Thomas Lynch
Publikováno v:
Nuclear Medicine Communications. 29:418-424
Division of Imaging, Kings College, PET Centre at St Thomas’ Hospital, Guys’ and St Thomas’ Foundation NHS Trust, London, Great Ormond Street Hospital for Sick Children, City and Royal Victoria Hospitals Belfast, Leeds Teaching Hospitals NHS Tr
Autor:
S F Hain
Publikováno v:
Cancer Imaging
Positron emission tomography (PET) in uro-oncology has been one of the slowest areas to develop. There are problems because of the excretion of tracer through the renal tract. Its use in prostate cancer has generally being disappointing, with PET bei
Autor:
S F Hain, Ignac Fogelman
Publikováno v:
The Cancer Journal. 10:121-127
Historically, nuclear medicine has had an important role in the differential diagnosis of liver tumors but has been largely superseded by other forms of conventional imaging, in particular computed tomographic portography. It remains helpful in diffi
Publikováno v:
The Journal of Bone and Joint Surgery. British volume. :315-321
Autor:
Michael Maisey, Andrew D Beggs, Michael O'Doherty, S F Hain, Ignac Fogelman, Kathleen M. Curran
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 29:542-546
The differentiation of benign versus malignant disease in a lesion identified on conventional imaging is a commonly encountered problem. Attempted biopsy is often unsuccessful or falsely reassuring and may lead to the patient being sent for more inva
Publikováno v:
British Journal of Cancer
Previous studies have shown that high uptake of 18F-fluoro-2-deoxy-glucose in head and neck cancer, as determined by the standardized uptake value on positron emission tomography scan, was associated with poor survival. The aim of this study was to c
Publikováno v:
Annals of Oncology. 11:1273-1280
Summary Purpose Optimum therapy for patients with Hodgkin's disease (HD) is determined by a number of prognostic factors, one of which is an accurate definition of extent of disease (stage). Computerised tomography is widely used in staging but canno
Publikováno v:
British Journal of Cancer
Differentiation of active disease from fibrosis/mature teratoma in patients with residual masses or identifying of sites of recurrence in patients with raised markers following treatment of their testicular cancer remains a problem.18F-fluorodeoxyglu
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 27:590-594
Testicular cancer is a rare tumour with the potential for cure at diagnosis. It is important, however, to identify those patients with metastases at presentation so as to ensure that the optimum treatment strategy is employed. Many criteria have been
Publikováno v:
Annals of Oncology. 11:S147-S150
Summary Background: The problem of residual masses on post-treatment CT scans is a continuing dilemma for the oncologist treating malignant lymphomas. These masses may contain active disease or represent only necrotic tumour which continues to shrink